BRIM Biotechnology Current Cash

BRIM Biotechnology (6885.TWO) currently reports a current cash of $800M as of December 2025. That compares with $500M in the prior-year period — up 58.8% year over year. Use the charts on this page to explore BRIM Biotechnology's current cash history and peer comparisons.

BRIM Biotechnology's current cash increased from $500M to $800M — a 58.8% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BRIM Biotechnology reported $800M in current cash as of December 2025. That compares with $500M in the prior-year period — up 58.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $800M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BRIM Biotechnology, and consider following 6885.TWO for alerts when major investors trade the stock.

BRIM Biotechnology is classified in the Healthcare sector. On current cash, it currently shows $800M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6885.TWO with unrelated industries.